Know Cancer

or
forgot password

Investigation of Pain and Symptom Burden in Patients With Newly Diagnosed Head and Neck Cancer


N/A
21 Years
N/A
Not Enrolling
Both
Head and Neck Cancer

Thank you

Trial Information

Investigation of Pain and Symptom Burden in Patients With Newly Diagnosed Head and Neck Cancer


OBJECTIVES:

- To pilot test a questionnaire measuring the collection of the following data from
patients with newly diagnosed head and neck cancer: head and neck cancer-related
symptoms, general demographics, pain control, general symptoms, mood, smoking and
drinking history, and quality of life.

- To identify questions that may be unclear or difficult for patients to understand.

- To determine the time required for each patient to complete the questionnaire and
assess the feasibility and burden to the patient.

- To determine the baseline incidence of symptoms and psychosocial issues in these
patients.

OUTLINE: Patients complete a timed questionnaire comprising questions of head and neck
symptoms, demographic information, pain control, symptom control, mood, smoking and drinking
history, and anxiety and depression under the supervision of the investigator.


Inclusion Criteria:



- Diagnosis of head or neck carcinoma

- Newly diagnosed disease

- Able to speak English

- Able to give informed consent

Exclusion Criteria:

Not specified

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Pilot questionnaire testing of related symptoms, general demographics, pain control, general symptoms, mood, smoking and drinking history, and quality of life

Outcome Description:

collection of the following data from newly diagnosed HNC patients: head and neck cancer-related symptoms • general demographics • pain control general symptoms • mood • smoking and drinking history • quality of life Questions will be identified that may be unclear or difficult for patients to understand for future revision.

Outcome Time Frame:

at time of patient exam

Safety Issue:

No

Principal Investigator

Barbara Murphy, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Vanderbilt-Ingram Cancer Center

Authority:

United States: Federal Government

Study ID:

VICC SUPP 0723

NCT ID:

NCT00655005

Start Date:

May 2007

Completion Date:

May 2008

Related Keywords:

  • Head and Neck Cancer
  • head and neck cancer
  • Head and Neck Neoplasms

Name

Location

Vanderbilt-Ingram Cancer CenterNashville, Tennessee  37232-6838